| pubmed-article:21607170 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21607170 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21607170 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:21607170 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:21607170 | lifeskim:mentions | umls-concept:C0389071 | lld:lifeskim |
| pubmed-article:21607170 | lifeskim:mentions | umls-concept:C0948265 | lld:lifeskim |
| pubmed-article:21607170 | lifeskim:mentions | umls-concept:C0041980 | lld:lifeskim |
| pubmed-article:21607170 | lifeskim:mentions | umls-concept:C1419320 | lld:lifeskim |
| pubmed-article:21607170 | lifeskim:mentions | umls-concept:C0857121 | lld:lifeskim |
| pubmed-article:21607170 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21607170 | pubmed:dateCreated | 2011-5-24 | lld:pubmed |
| pubmed-article:21607170 | pubmed:abstractText | Adipokines have been suggested for their potential use in tracking the clinical progress in the subjects with metabolic syndrome (MS). To investigate the relationship between the serum levels of adipokines {adiponectin and retinol-binding protein 4 (RBP4)} and the serum level of uric acid in hypertensive (HTN) patients with MS. | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21607170 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21607170 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:21607170 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:21607170 | pubmed:issn | 1738-5555 | lld:pubmed |
| pubmed-article:21607170 | pubmed:author | pubmed-author:SeungKi BaeKB | lld:pubmed |
| pubmed-article:21607170 | pubmed:author | pubmed-author:KimHee-YeolHY | lld:pubmed |
| pubmed-article:21607170 | pubmed:author | pubmed-author:YounHo-JoongH... | lld:pubmed |
| pubmed-article:21607170 | pubmed:author | pubmed-author:KimJae-HyungJ... | lld:pubmed |
| pubmed-article:21607170 | pubmed:author | pubmed-author:ChangKiyukK | lld:pubmed |
| pubmed-article:21607170 | pubmed:author | pubmed-author:IhmSang-HyunS... | lld:pubmed |
| pubmed-article:21607170 | pubmed:author | pubmed-author:ShinWoo-Seung... | lld:pubmed |
| pubmed-article:21607170 | pubmed:author | pubmed-author:ChungWook-Sun... | lld:pubmed |
| pubmed-article:21607170 | pubmed:author | pubmed-author:ParkHun-JunHJ | lld:pubmed |
| pubmed-article:21607170 | pubmed:author | pubmed-author:ParkChan... | lld:pubmed |
| pubmed-article:21607170 | pubmed:author | pubmed-author:KimPum-JunPJ | lld:pubmed |
| pubmed-article:21607170 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21607170 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:21607170 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21607170 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21607170 | pubmed:pagination | 198-202 | lld:pubmed |
| pubmed-article:21607170 | pubmed:dateRevised | 2011-7-28 | lld:pubmed |
| pubmed-article:21607170 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21607170 | pubmed:articleTitle | Relationship between plasma adiponectin, retinol-binding protein 4 and uric Acid in hypertensive patients with metabolic syndrome. | lld:pubmed |
| pubmed-article:21607170 | pubmed:affiliation | Department of Cardiology, College of Medicine, The Catholic University of Korea, Bucheon St. Mary' Hospital, Bucheon, Korea. | lld:pubmed |
| pubmed-article:21607170 | pubmed:publicationType | Journal Article | lld:pubmed |
